ATE238310T1 - Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung - Google Patents

Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung

Info

Publication number
ATE238310T1
ATE238310T1 AT97940434T AT97940434T ATE238310T1 AT E238310 T1 ATE238310 T1 AT E238310T1 AT 97940434 T AT97940434 T AT 97940434T AT 97940434 T AT97940434 T AT 97940434T AT E238310 T1 ATE238310 T1 AT E238310T1
Authority
AT
Austria
Prior art keywords
cefditors
pivoxil
production
crystalline substance
crystalline
Prior art date
Application number
AT97940434T
Other languages
English (en)
Inventor
Kiyoshi Yasui
Masahiro Onodera
Masamichi Sukegawa
Tatsuo Watanabe
Yuichi Yamamoto
Yasushi Murai
Katsuharu Iinuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE238310T1 publication Critical patent/ATE238310T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
AT97940434T 1996-09-20 1997-09-19 Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung ATE238310T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24956196 1996-09-20
PCT/JP1997/003340 WO1998012200A1 (en) 1996-09-20 1997-09-19 A crystalline substance of cefditoren pivoxyl and the production of the same

Publications (1)

Publication Number Publication Date
ATE238310T1 true ATE238310T1 (de) 2003-05-15

Family

ID=17194838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97940434T ATE238310T1 (de) 1996-09-20 1997-09-19 Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung

Country Status (25)

Country Link
US (2) US6294669B1 (de)
EP (1) EP0937083B1 (de)
JP (1) JP3403206B2 (de)
KR (1) KR100441907B1 (de)
CN (1) CN1116299C (de)
AR (1) AR008483A1 (de)
AT (1) ATE238310T1 (de)
AU (1) AU714735B2 (de)
BR (1) BR9712072A (de)
CA (1) CA2265686C (de)
CZ (1) CZ295199B6 (de)
DE (1) DE69721290T2 (de)
EA (1) EA001526B1 (de)
ES (1) ES2198593T3 (de)
HU (1) HU224196B1 (de)
ID (1) ID22064A (de)
IL (1) IL129016A (de)
NZ (1) NZ334883A (de)
PL (1) PL189548B1 (de)
PT (1) PT937083E (de)
RO (1) RO120196B1 (de)
SK (1) SK284973B6 (de)
TR (1) TR199900614T2 (de)
UA (1) UA55426C2 (de)
WO (1) WO1998012200A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012200A1 (en) * 1996-09-20 1998-03-26 Meiji Seika Kaisha Ltd. A crystalline substance of cefditoren pivoxyl and the production of the same
HU230295B1 (hu) 1998-01-07 2015-12-28 Meiji Seika Pharma Co., Ltd. Kristálytanilag stabil, amorf, cephalosporin tartalmú készítmény és eljárás előállítására
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
HU226640B1 (en) * 1999-10-18 2009-05-28 Egis Gyogyszergyar Nyilvanosan Process for producing amorphous atorvastatin calcium salt
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
EP1560584B1 (de) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab-i-inhibitoren
DE60336149D1 (de) * 2002-08-16 2011-04-07 Immunogen Inc Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
AU2003235962A1 (en) * 2002-10-02 2004-04-23 Meiji Seika Kaisha, Ltd. Antibacterial medicinal composition of enhanced oral absorptivity
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
EP1575951B1 (de) * 2002-12-06 2014-06-25 Debiopharm International SA Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
ES2329244T3 (es) * 2003-03-27 2009-11-24 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
US8088387B2 (en) * 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
EP1660505A2 (de) * 2003-08-14 2006-05-31 Ranbaxy Laboratories Limited Verfahren zur selektiven herstellung des z-isomers von cefditoren und dessen pharmazeutisch unbedenklichen salzen und estern
CN1863535A (zh) 2003-10-08 2006-11-15 明治制果株式会社 含有头孢托仑匹伏酯的非晶性抗菌组合物
CN1902207A (zh) * 2003-11-07 2007-01-24 兰贝克赛实验室有限公司 高纯度3－(2－取代乙烯基)头孢菌素的制备方法
JP2005162696A (ja) * 2003-12-04 2005-06-23 Nichiko Pharmaceutical Co Ltd 溶出性に優れたセフジトレンピボキシル製剤
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
WO2006024900A1 (en) * 2004-08-31 2006-03-09 Ranbaxy Laboratories Limited Highly pure cefditoren pivoxil
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
US20080069879A1 (en) * 2006-05-02 2008-03-20 Ravishekhar Bhiwgade Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (de) 2007-02-16 2014-08-20 Debiopharm Int Sa Salze, prodrugs und polymorphe von fab-i-inhibitoren
EP2520578A1 (de) 2011-05-06 2012-11-07 Lupin Limited Verfahren zur Reinigung von Cephalosporinen
CN103421025B (zh) * 2012-05-21 2016-05-11 上海医药工业研究院 制备7α-甲氧基头孢菌素C的方法
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
KR101561963B1 (ko) * 2013-05-23 2015-10-22 영진약품공업 주식회사 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법
CN103665002B (zh) * 2013-12-18 2016-02-03 成都医路康医学技术服务有限公司 一种头孢妥仑匹酯的制备方法
EP3244879A1 (de) 2015-01-16 2017-11-22 Ögün, Yusuf Toktamis Cefditoren-pivoxil-zusammensetzungen mit verbesserter stabilität und herstellungsverfahren dafür
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58487B1 (en) 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
WO1995009171A1 (en) * 1993-09-29 1995-04-06 Meiji Seika Kaisha, Ltd. Novel cephalosporin derivative
DE69427312T2 (de) * 1993-11-17 2001-08-23 Biochemie Ges.M.B.H., Kundl Trennung von Cephalosporinisomeren
WO1998012200A1 (en) * 1996-09-20 1998-03-26 Meiji Seika Kaisha Ltd. A crystalline substance of cefditoren pivoxyl and the production of the same

Also Published As

Publication number Publication date
CN1234036A (zh) 1999-11-03
CA2265686A1 (en) 1998-03-26
BR9712072A (pt) 1999-08-24
EP0937083B1 (de) 2003-04-23
CA2265686C (en) 2006-10-31
JP2001500521A (ja) 2001-01-16
AU714735B2 (en) 2000-01-13
KR100441907B1 (ko) 2004-07-27
AR008483A1 (es) 2000-01-19
US20020002279A1 (en) 2002-01-03
DE69721290D1 (de) 2003-05-28
AU4222297A (en) 1998-04-14
HUP9903454A3 (en) 2001-04-28
SK284973B6 (sk) 2006-03-02
SK35499A3 (en) 2000-03-13
EA199900311A1 (ru) 1999-10-28
HUP9903454A2 (hu) 2000-03-28
RO120196B1 (ro) 2005-10-28
CZ97599A3 (cs) 1999-08-11
US6441162B2 (en) 2002-08-27
IL129016A0 (en) 2000-02-17
NZ334883A (en) 2000-09-29
JP3403206B2 (ja) 2003-05-06
ID22064A (id) 1999-08-26
IL129016A (en) 2003-01-12
CZ295199B6 (cs) 2005-06-15
UA55426C2 (uk) 2003-04-15
EP0937083A1 (de) 1999-08-25
HK1022912A1 (en) 2000-08-25
TR199900614T2 (xx) 1999-06-21
CN1116299C (zh) 2003-07-30
HU224196B1 (hu) 2005-06-28
WO1998012200A1 (en) 1998-03-26
PL332314A1 (en) 1999-08-30
KR20000048496A (ko) 2000-07-25
DE69721290T2 (de) 2004-01-22
PT937083E (pt) 2003-08-29
PL189548B1 (pl) 2005-08-31
US6294669B1 (en) 2001-09-25
ES2198593T3 (es) 2004-02-01
EA001526B1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
ATE238310T1 (de) Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung
DE69504892D1 (de) Mischelement und Verfahren zu dessen Herstellung
DE69636166D1 (de) Klebstoffzusammensetzung und verfahren zu ihrer herstellung
DE69331176D1 (de) Knochenzement und Verfahren zu seiner Herstellung
DE69733416D1 (de) Erythromycine und verfahren zu ihrer herstellung
DE69532895D1 (de) Biomaterial und verfahren zu dessen herstellung
DE69518830D1 (de) Polypropylenreaktionsmischung und verfahren zu ihrer herstellung
DE69720523D1 (de) Polyolefin-polyethylenoxid-mischungen und verfahren zu deren herstellung
DE69409907D1 (de) Hochmicroporöse Kohlenstoffe und Verfahren zu ihrer Herstellung
DE69611599D1 (de) Halbaromatische polyamidzusamensetzung und verfahren zu ihrer herstellung
DE69616516D1 (de) Wasserschutzzusammensetzungen und verfahren zu deren herstellung
DE69620405D1 (de) Verbesserte polyarylenetherzusammensetzungen und verfahren zu ihrer herstellung
DE69703993D1 (de) Einbügelbarer Einlagestoff und Verfahren zu dessen Herstellung
ATE220666T1 (de) 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
DE69626009D1 (de) Pyrrolidinylhydroxamsäuren und verfahren zu ihrer herstellung
DE69433296D1 (de) Eisen-lactoferrin kombination und verfahren zu ihrer herstellung
DE69510774D1 (de) Katschukzusammensetzung und verfahren zu ihrer herstellung
DE69801795D1 (de) Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung
ATA75297A (de) Dekorlaminat und verfahren zu seiner herstellung
DE69738570D1 (de) Konzentrierte wässerige tensidzusammensetzungen von betaintyp und verfahren zu deren herstellung
DE69528271D1 (de) Flüssigkristalline copolyesterimide und verfahren zu ihrer herstellung
DE69523571D1 (de) Pyridylimidazol-derivate und verfahren zu ihrer herstellung
DE69527445D1 (de) Aminooligosaccharid-derivate und verfahren zu ihrer herstellung
DE69628754D1 (de) Leicht absorbierbares kalzium enthaltende zusammensetzung und verfahren zu ihrer herstellung
DE69735099D1 (de) Antibiotika rk-1061 und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0937083

Country of ref document: EP

EEFA Change of the company name